https://cotainc.kinsta.cloud/research/prevalence-of-clinically-meaningful-prognostic-variability-in-cancer-an-analysis-using-a-new-taxonomy-system/ 2015-05-20T10:32:27+00:00 https://cotainc.kinsta.cloud/research/utilization-and-clinical-impact-of-genomic-profiling-for-egfr-and-alk-in-non-squamous-non-small-cell-lung-cancer-nsclc-in-the-community-setting/ 2015-05-20T11:30:45+00:00 https://cotainc.kinsta.cloud/research/characterization-of-early-stage-breast-cancer-patient-management-in-a-practice-setting-with-the-21-gene-breast-cancer-assay/ 2015-05-27T11:42:56+00:00 https://cotainc.kinsta.cloud/research/development-of-a-patient-reported-outcome-pro-instrument-to-facilitate-timing-of-end-of-life-eol-discussions-in-patients-with-advanced-cancers/ 2015-10-10T10:21:02+00:00 https://cotainc.kinsta.cloud/research/a-new-digital-classification-schema-to-detect-treatment-variances-and-enable-value-based-payment-reforms/ 2016-03-01T11:30:08+00:00 https://cotainc.kinsta.cloud/research/s72-adherence-to-the-2013-cap-iaslc-amp-molecular-testing-guidelines-in-non-small-cell-lung-cancer-nsclc-in-the-community-setting-opportunities-for-improvement/ 2016-04-27T11:28:19+00:00 https://cotainc.kinsta.cloud/research/real-world-comparative-effectiveness-of-albumin-bound-paclitaxel-plus-carboplatin-nab-p-c-versus-solvent-based-paclitaxel-plus-carboplatin-sb-p-c-in-first-line-treatment-of-advanced-squamous-cell/ 2016-05-01T17:19:10+00:00 https://cotainc.kinsta.cloud/research/are-patients-with-advanced-cancer-concerned-about-financial-toxicity/ 2016-05-20T10:15:38+00:00 https://cotainc.kinsta.cloud/research/early-economic-benefits-of-gene-expression-profiling-using-a-21-gene-panel-among-patients-with-early-stage-lymph-node-negative-hormone-receptor-positive-her2-neu-oncogene-negative-breast-cancer/ 2016-05-20T11:39:28+00:00 https://cotainc.kinsta.cloud/research/growth-factor-use-and-costs-in-breast-cancer-patients-undergoing-adjuvant-therapy/ 2016-05-20T11:41:22+00:00 https://cotainc.kinsta.cloud/research/a-patient-reported-outcome-instrument-to-facilitate-timing-of-end-of-life-discussions-among-patients-with-advanced-cancers/ 2016-06-27T10:12:41+00:00 https://cotainc.kinsta.cloud/research/validation-of-the-living-with-cancer-lwc-pro-tool-for-identifying-patients-pts-with-cancer-appropriate-for-end-of-life-care-consultations/ 2016-10-09T10:17:06+00:00 https://cotainc.kinsta.cloud/research/are-patients-with-cancer-concerned-about-burdening-their-families/ 2016-10-09T10:18:59+00:00 https://cotainc.kinsta.cloud/research/impact-of-charlson-comorbidity-index-cci-and-refining-the-mipi-index-in-mantle-cell-lymphoma-mcl/ 2016-12-02T18:26:03+00:00 https://cotainc.kinsta.cloud/research/identifying-latent-factors-in-the-living-with-cancer-lwc-patient-reported-outcomes-pro-tool-for-patients-with-advanced-malignancies/ 2017-04-03T11:55:24+00:00 https://cotainc.kinsta.cloud/research/genomic-profiling-of-advanced-non-small-cell-lung-cancer-in-community-settings-gaps-and-opportunities/ 2017-04-13T11:24:58+00:00 https://cotainc.kinsta.cloud/research/patterns-of-treatment-for-newly-diagnosed-and-relapsed-refractory-peripheral-t-cell-lymphoma-in-the-community-setting/ 2017-05-01T17:27:03+00:00 https://cotainc.kinsta.cloud/research/predictive-value-of-the-patient-reported-outcome-living-with-cancer-instrument-on-overall-survival-in-advanced-cancer-patients-a-tool-for-guiding-timing-of-palliative-care-consultat/ 2017-05-30T11:53:41+00:00 https://cotainc.kinsta.cloud/research/prognostic-value-of-the-absolute-lymphocyte-to-monocyte-alc-amc-ratio-on-overall-survival-among-patients-with-mantle-cell-lymphoma/ 2017-05-30T17:24:00+00:00 https://cotainc.kinsta.cloud/research/treatment-of-peripheral-t-cell-lymphoma-in-community-settings/ 2017-06-17T17:22:30+00:00 https://cotainc.kinsta.cloud/research/real-world-economic-value-of-a-21-gene-assay-in-early-stage-breast-cancer/ 2017-12-01T12:37:39+00:00 https://cotainc.kinsta.cloud/research/treatment-of-high-risk-dlbcl-with-da-r-epoch-in-those-unable-to-tolerate-intensive-chemotherapy-well-tolerated-and-effective-but-inadequate-in-double-triple-hit-or-expressing-dlbcl/ 2017-12-07T18:25:15+00:00 https://cotainc.kinsta.cloud/research/incidence-and-survival-impact-of-self-reported-symptom-and-psychological-distress-among-patients-with-multiple-myeloma/ 2017-12-11T12:58:03+00:00 https://cotainc.kinsta.cloud/research/oncologists-perspectives-on-barriers-to-effective-communication-about-genomic-test-results-and-preferences-for-communication-aides/ 2018-04-27T11:20:36+00:00 https://cotainc.kinsta.cloud/research/utilization-of-a-precise-clinically-relevant-digital-classification-system-to-identify-variation-in-care-and-costs-among-patients-with-breast-cancer/ 2018-05-28T10:28:17+00:00 https://cotainc.kinsta.cloud/research/profiling-for-microsatellite-instability-msi-and-mismatch-repair-mmr-among-patients-with-colon-cancer-in-real-world-settings/ 2018-06-01T11:22:57+00:00 https://cotainc.kinsta.cloud/research/immunotherapy-or-targeted-therapy-as-initial-therapy-for-advanced-melanoma-a-real-world-analysis/ 2018-09-18T17:28:10+00:00 https://cotainc.kinsta.cloud/research/p2-01-42-impact-of-tobacco-smoking-on-outcomes-in-patients-with-metastatic-non-small-cell-lung-cancer-in-the-era-of-targeted-therapy/ 2018-09-25T10:27:26+00:00 https://cotainc.kinsta.cloud/research/a-patient-reported-outcome-instrument-to-assess-symptom-burden-and-predict-survival-in-patients-with-advanced-cancer-flipping-the-paradigm-to-improve-timing-of-palliative-and-end-of-life-discussions/ 2018-09-28T11:50:50+00:00 https://cotainc.kinsta.cloud/research/real-world-incidence-severity-and-timing-of-adverse-events-aes-among-patients-with-metastatic-non-small-cell-lung-cancer-nsclc-receiving-second-line-2l-immuno-oncology-io-therapy-vs-chemother/ 2018-10-01T17:18:08+00:00 https://cotainc.kinsta.cloud/research/development-of-a-precise-clinically-relevant-digital-classification-schema-for-cancer/ 2018-10-16T10:26:23+00:00 https://cotainc.kinsta.cloud/research/abstract-p4-14-05-confirmation-of-the-tailorx-21-gene-expression-trial-using-a-real-world-observational-database/ 2019-02-15T17:56:36+00:00 https://cotainc.kinsta.cloud/research/treatment-patterns-and-outcomes-among-t1114-myeloma-patients-in-a-real-world-setting/ 2019-05-26T11:09:23+00:00 https://cotainc.kinsta.cloud/research/the-unforeseen-business-and-medical-consequences-of-ehr-data-collection-for-a-real-world-data-multiple-myeloma-registry/ 2019-05-26T11:34:45+00:00 https://cotainc.kinsta.cloud/research/rates-of-genotyping-for-kras-nras-braf-microsatellite-instability-msi-and-mismatch-repair-mmr-in-metastatic-colon-cancer-patients-gaps-and-implications/ 2019-05-26T16:59:18+00:00 https://cotainc.kinsta.cloud/research/real-world-characterization-of-advanced-metastatic-non-small-cell-lung-cancer-ansclc-patients-pts-with-rapid-disease-progression-rdp/ 2019-05-26T17:17:14+00:00 https://cotainc.kinsta.cloud/research/an-exploratory-analysis-of-real-world-end-points-for-assessing-outcomes-among-immunotherapy-treated-patients-with-advanced-non-small-cell-lung-cancer/ 2019-07-23T17:15:54+00:00 https://cotainc.kinsta.cloud/research/differential-impact-of-cognitive-computing-augmented-by-real-world-evidence-on-novice-and-expert-oncologists/ 2019-09-11T11:17:47+00:00 https://cotainc.kinsta.cloud/research/chromosome-1q-amplification-is-associated-with-a-history-of-prior-malignancies-among-patients-newly-diagnosed-with-multiple-myeloma/ 2019-11-13T12:07:56+00:00 https://cotainc.kinsta.cloud/research/the-unforeseen-medical-and-business-challenges-found-when-integrating-abstracted-data-from-disparate-ehr-systems-while-building-the-curecloud-direct-to-patient-multiple-myeloma-registry/ 2019-11-13T12:33:03+00:00 https://cotainc.kinsta.cloud/research/genomic-profiling-for-kras-nras-braf-microsatellite-instability-and-mismatch-repair-deficiency-among-patients-with-metastatic-colon-cancer/ 2019-12-06T17:57:55+00:00 https://cotainc.kinsta.cloud/research/74p-cost-of-adverse-events-aes-with-second-line-2l-immuno-oncology-agents-io-and-chemotherapy-chemo-in-advanced-non-small-cell-lung-cancer-ansclc-in-the-real-world/ 2019-12-27T12:45:01+00:00 https://cotainc.kinsta.cloud/research/karmma-rw-a-study-of-real-world-treatment-patterns-in-heavily-pretreated-patients-with-relapsed-and-refractory-multiple-myeloma-rrmm-and-comparison-of-outcomes-to-karmma/ 2020-05-25T11:00:31+00:00 https://cotainc.kinsta.cloud/research/disparities-in-clinical-characteristics-and-treatment-of-multiple-myeloma-in-african-american-patients/ 2020-05-25T11:04:39+00:00 https://cotainc.kinsta.cloud/research/assessing-real-world-clinical-response-in-patients-with-multiple-myeloma-mm-a-survey-of-the-literature/ 2020-05-25T11:06:31+00:00 https://cotainc.kinsta.cloud/research/trends-in-immunotherapy-use-in-patients-with-advanced-non-small-cell-lung-cancer-ansclc-patients-analysis-of-real-world-data/ 2020-05-25T17:13:25+00:00 https://cotainc.kinsta.cloud/research/overall-survival-os-in-advanced-non-small-cell-lung-cancer-ansclc-patients-treated-with-frontline-chemotherapy-or-immunotherapy-by-comorbidity-a-real-world-data-rwd-collaboration/ 2020-05-25T17:14:37+00:00 https://cotainc.kinsta.cloud/research/incorporating-molecular-markers-in-standard-prognostic-models-for-dlbcl-patients-using-real-world-data/ 2020-05-25T17:21:36+00:00 https://cotainc.kinsta.cloud/research/real-world-treatment-patterns-and-outcomes-of-patients-with-functional-high-risk-early-relapse-multiple-myeloma/ 2020-11-05T12:02:43+00:00 https://cotainc.kinsta.cloud/research/prevalence-and-survival-impact-of-self-reported-symptom-and-psychological-distress-among-patients-with-multiple-myeloma/ 2020-12-03T12:47:41+00:00 https://cotainc.kinsta.cloud/research/associations-between-amplification-1q-and-prior-cancer-in-a-real-world-de-novo-myeloma-cohort/ 2021-01-04T11:53:56+00:00 https://cotainc.kinsta.cloud/research/amivantamab-compared-with-real-world-therapies-in-patients-with-nsclc-with-egfr-exon-20-insertion-mutations-who-have-progressed-after-platinum-doublet-chemotherapy/ 2021-05-28T10:39:27+00:00 https://cotainc.kinsta.cloud/research/karmma-rw-comparison-of-idecabtagene-vicleucel-with-real-world-outcomes-in-relapsed-and-refractory-multiple-myeloma/ 2021-07-18T10:58:24+00:00 https://cotainc.kinsta.cloud/research/pd61-08-real-world-treatment-patterns-and-time-to-metastatic-disease-development-of-patients-with-high-risk-non-metastatic-prostate-cancer/ 2021-09-01T11:12:41+00:00 https://cotainc.kinsta.cloud/research/ma14-01-distribution-and-detectability-of-egfr-exon-20-insertion-variants-in-non-small-cell-lung-cancer/ 2021-09-13T10:24:33+00:00 https://cotainc.kinsta.cloud/research/1259p-real-world-next-generation-sequencing-ngs-and-treatment-tx-patterns-in-non-small-cell-lung-cancer-nsclc-patients-pts-with-met-exon-14-skipping-mutations-metex14/ 2021-09-26T10:56:21+00:00 https://cotainc.kinsta.cloud/research/mm-123-real-world-study-of-treatment-patterns-in-heavily-pretreated-relapsed-refractory-multiple-myeloma-rrmm-in-the-us/ 2021-09-27T10:47:47+00:00 https://cotainc.kinsta.cloud/research/p-119-evaluation-of-real-world-frontline-treatment-for-multiple-myeloma-by-race/ 2021-10-02T00:53:33+00:00 https://cotainc.kinsta.cloud/research/real-world-overall-survival-using-oncology-electronic-health-record-data-friends-of-cancer-research-pilot/ 2021-10-16T17:04:21+00:00 https://cotainc.kinsta.cloud/research/the-friends-of-cancer-research-real-world-data-collaboration-pilot-2-0-methodological-recommendations-from-oncology-case-studies/ 2021-10-18T17:05:37+00:00 https://cotainc.kinsta.cloud/research/treatment-patterns-and-outcomes-of-patients-with-double-class-refractory-or-triple-class-refractory-multiple-myeloma-a-retrospective-us-electronic-health-record-database-study/ 2021-11-05T10:50:55+00:00 https://cotainc.kinsta.cloud/research/realm-op-rw001-comparing-the-characteristics-and-clinical-outcomes-of-patients-with-relapsed-refractory-multiple-myeloma-in-the-real-world-to-patients-receiving-melflufen-in-the-horizon-study/ 2021-11-05T10:55:59+00:00 https://cotainc.kinsta.cloud/research/evaluation-of-functional-and-cytogenetic-high-risk-multiple-myeloma-using-real-world-data/ 2021-11-05T16:43:52+00:00 https://cotainc.kinsta.cloud/wp-content/uploads/2022/04/evaluationoffunctional-scaled-1.jpeg https://cotainc.kinsta.cloud/research/development-of-an-inclusive-risk-prognostic-index-for-newly-diagnosed-multiple-myeloma/ 2021-11-06T00:43:09+00:00 https://cotainc.kinsta.cloud/research/frontline-venetoclax-ven-based-combination-therapy-in-older-adults-with-acute-myeloid-leukemia-treated-in-the-real-world-setting-a-multi-institutional-retrospective-study-2/ 2021-11-23T18:03:34+00:00 https://cotainc.kinsta.cloud/research/identification-of-barriers-of-car-t-utilization-in-patients-with-diffuse-large-b-cell-lymphoma-2/ 2021-11-23T18:20:20+00:00 https://cotainc.kinsta.cloud/wp-content/uploads/2022/04/identificationofbarriers-scaled-1.jpeg https://cotainc.kinsta.cloud/research/reality-check-real-world-evidence-to-support-therapeutic-development-in-hematologic-malignancies/ 2022-03-03T05:00:46+00:00 https://cotainc.kinsta.cloud/wp-content/uploads/2022/04/realitycheck-scaled-1.jpeg https://cotainc.kinsta.cloud/research/treatment-effectiveness-in-a-rare-oncology-indication-lessons-from-an-external-control-cohort-study/ 2022-06-05T10:31:37+00:00 https://cotainc.kinsta.cloud/research/treatment-patterns-and-overall-survival-of-patients-with-double-class-and-triple-class-refractory-multiple-myeloma-a-us-electronic-health-record-database-study/ 2022-06-13T10:44:39+00:00 https://cotainc.kinsta.cloud/research/amivantamab-compared-with-real-world-therapies-in-patients-with-advanced-non-small-cell-lung-cancer-harboring-egfr-exon-20-insertion-mutations-who-progressed-after-platinum-based-chemotherapy/ 2022-06-26T10:34:53+00:00 https://cotainc.kinsta.cloud/research/characteristics-and-clinical-outcomes-of-patients-with-relapsed-refractory-diffuse-large-b-cell-lymphoma-who-received-at-least-3-lines-of-therapies/ 2022-06-27T10:29:59+00:00 https://cotainc.kinsta.cloud/research/p1182-real-world-characteristics-and-clinical-outcomes-in-relapse-refractory-diffuse-large-b-cell-lymphoma-patients-who-received-car-t-therapy/ 2022-06-27T10:32:02+00:00 https://cotainc.kinsta.cloud/research/co154-ramucirumabdocetaxel-post-immune-checkpoint-inhibitors-icis-and-platinum-based-chemotherapy-chemo-in-advanced-or-metastatic-non-small-cell-lung-cancer-ansclc-learnings-from-the-treat-lun/ 2022-07-01T11:56:40+00:00 https://cotainc.kinsta.cloud/research/agreement-between-real-world-physician-response-assessment-the-2017-european-leukemianet-eln-criteria-in-acute-myeloid-leukemia-aml-a-comparative-analysis/ 2022-08-15T12:57:57+00:00 https://cotainc.kinsta.cloud/research/comparative-effectiveness-of-lisocabtagene-maraleucel-liso-cel-in-pilot-in-patients-pt-with-relapsed-or-refractory-r-r-large-b-cell-lymphoma-lbcl-for-whom-transplant-was-not-intended-tni-ver/ 2022-11-15T11:34:29+00:00 https://cotainc.kinsta.cloud/research/real-world-outcomes-in-relapsed-refractory-dlbcl-patients-who-received-polatuzumab-vedotin-plus-bendamustine-and-rituximab-or-tafasitamab-plus-lenalidomide-by-line-of-therapy/ 2022-11-15T11:36:35+00:00 https://cotainc.kinsta.cloud/research/real-world-outcomes-in-patients-with-relapsed-or-refractory-diffuse-large-b-cell-lymphoma-treated-with-standard-of-care-a-cota-database-analysis/ 2022-11-15T11:38:12+00:00 https://cotainc.kinsta.cloud/research/treatment-patterns-and-patient-outcomes-in-relapsed-refractory-multiple-myeloma-rrmm-stratified-by-exposure-to-lenalidomide-or-anti-cd38-therapy-and-double-class-refractory-status-a-retrospective-e/ 2022-11-15T11:42:39+00:00 https://cotainc.kinsta.cloud/research/real-world-first-line-treatment-and-outcomes-of-patients-with-chronic-lymphocytic-leukemia-cll-treated-with-bruton-tyrosine-kinase-inhibitor-btki-or-b-cell-lymphoma-2-bcl2-therapy/ 2022-11-15T17:19:37+00:00 https://cotainc.kinsta.cloud/research/real-world-treatment-patterns-among-patients-with-newly-diagnosed-nd-acute-myeloid-leukemia-aml-in-the-united-states-us/ 2022-11-15T17:22:20+00:00 https://cotainc.kinsta.cloud/research/patient-and-clinician-reported-performance-status-in-patients-with-multiple-myeloma-treated-in-the-united-states-using-real-world-data/ 2022-11-15T17:23:49+00:00 https://cotainc.kinsta.cloud/research/continuous-maintenance-maint-capecitabine-cape-dosing-for-colorectal-crc-and-pancreatic-cancers-pc-a-single-institution-retrospective-real-world-study/ 2023-01-24T11:40:07+00:00 https://cotainc.kinsta.cloud/research/distribution-and-detectability-of-egfr-exon-20-insertion-variants-in-nsclc/ 2023-02-03T12:50:22+00:00 https://cotainc.kinsta.cloud/research/abstract-p6-08-11-hyperglycemia-in-hispanic-mbc-patients-treated-with-alpelisib-single-institution-retrospective-study/ 2023-03-01T12:16:43+00:00 https://cotainc.kinsta.cloud/research/metastatic-breast-cancer-mbc-at-a-tertiary-care-cancer-institute/ 2023-03-31T11:04:36+00:00 https://cotainc.kinsta.cloud/research/hsr23-106-real-world-study-of-disease-free-survival-and-associated-patient-characteristics-in-early-stage-non-small-cell-lung-cancer-nsclc-a-retrospective-observational-study/ 2023-03-31T11:43:13+00:00 https://cotainc.kinsta.cloud/research/the-cota-nodal-address-model-a-novel-digital-classification-system-identifies-variances-in-cancer-care-cost-to-support-value-based-care-delivery/ 2023-04-28T10:25:52+00:00 https://cotainc.kinsta.cloud/research/real-world-rw-use-of-venetoclax-ven-in-patients-pts-with-acute-myeloid-leukemia-aml-in-a-us-rwe-database-cota/ 2023-05-30T21:24:17+00:00 https://cotainc.kinsta.cloud/research/outcomes-among-hispanic-metastatic-breast-cancer-patients-treated-with-alpelisib-and-fulvestrant-single-institution-retrospective-study/ 2023-05-30T21:27:49+00:00 https://cotainc.kinsta.cloud/research/racial-and-ethnic-representation-in-large-b-cell-lymphoma-trials-and-real-world-databases/ 2023-05-30T21:50:12+00:00 https://cotainc.kinsta.cloud/research/real-world-rw-treatment-tx-patterns-of-patients-pts-with-higher-risk-myelodysplastic-syndrome-mds-in-a-us-rwe-database-cota/ 2023-05-31T12:08:38+00:00 https://cotainc.kinsta.cloud/research/increased-real-world-biomarker-test-utilization-in-patients-with-early-stage-non-small-cell-lung-cancer-in-the-united-states-2011-to-2021/ 2023-06-01T11:45:58+00:00 https://cotainc.kinsta.cloud/research/abstract-967-real-world-transcriptomic-biomarkers-as-replacement-for-immunohistochemistry-and-fish-studies-in-breast-cancer/ 2024-04-19T16:56:14+00:00 https://cotainc.kinsta.cloud/wp-content/uploads/2023/05/abstract967.jpg https://cotainc.kinsta.cloud/research/an-indirect-comparison-of-elranatamabs-elra-objective-response-rate-orr-from-magnetismm-3-mm-3-vs-real-world-external-control-arms-in-triple-class-refractory-tcr-multiple-myeloma-mm/ 2024-04-19T16:56:29+00:00 https://cotainc.kinsta.cloud/wp-content/uploads/2023/05/elra-research.jpg https://cotainc.kinsta.cloud/research/real-world-response-endpoints-in-patients-with-mnsclc-treated-with-chemotherapy-across-real-world-datasets/ 2024-04-19T16:56:43+00:00 https://cotainc.kinsta.cloud/wp-content/uploads/2023/05/mNSCLC-research-2.jpg